CVS Health Corp issued an optimistic guidance for 2025 stemming from the expected recovery in its insurance business — ...

CVS Health is seeing signs of stabilization in key business areas, prompting Leerink Partners to upgrade the stock from Market Perform to Outperform and raise its price target to $75 per share in a ...

CVS Health Corporation reported financial results for the fourth quarter and full year of 2024, highlighting challenges ...

A Leerink analyst says CVS is starting to benefit from stabilization in its Aetna health-insurance and pharmacy-benefits ...

However, the healthcare giant beat Wall Street expectations in earnings and revenue in the fourth quarter, sending CVS stock ...

CVS Health (CVS) stock was upgraded by Cantor Fitzgerald to Overweight after the company posted strong Q4 results earlier in ...

CVS is trying to turn around its drugstore chain and insurance business. The company spent a smaller percentage of premium ...

Larry McGrath; Executive Vice President, Chief Strategy Officer and Chief Strategic Advisor to the CEO of CVS Health; CVS Health Corp David Joyner; President and Chief Executive Officer; CVS Health ...

BofA raised the firm’s price target on CVS Health (CVS) to $75 from $63 and keeps a Buy rating on the shares. Aetna can add $3-$4 per share of ...

CVS Health (CVS) stock soared about 15% yesterday after posting upbeat fourth-quarter results, with revenues and earnings surpassing analysts’ ...

CVS Health CVS turned in solid fourth-quarter results, and its 2025 guidance for 6%-11% adjusted EPS growth without any share ...

CVS appears uniquely positioned to improve health outcomes, and we appreciate management's focus on better leveraging its assets through digital and other means to bring a more consumer-centric ...